Cargando…
Assessment of Helicobacter pylori eradication in patients on NSAID treatment
BACKGROUND: In this post-hoc analysis of a randomized, double blind, placebo controlled trial, we measured the sensitivity and specificity of Helicobacter pylori IgG-antibody titer changes, hematoxylin and eosin (H&E) stains, immunohistochemical (IHC) stains and culture results in NSAID using pa...
Autores principales: | Vonkeman, Harald E, deLeest, HTJI, van deLaar, MAFJ, vanBaarlen, J, Steen, KSS, Lems, WF, Bijlsma, JWJ, Kuipers, EJ, Houben, HHML, Janssen, M, Dijkmans, BAC |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515350/ https://www.ncbi.nlm.nih.gov/pubmed/23006807 http://dx.doi.org/10.1186/1471-230X-12-133 |
Ejemplares similares
-
Efficacy of serology driven “test and treat strategy” for eradication of H. pylori in patients with rheumatic disease in the Netherlands
por: de Leest, H. T. J. I., et al.
Publicado: (2011) -
Multidrug resistance proteins and DMARD efficacy in rheumatoid arthritis
por: Jansen, G, et al.
Publicado: (2004) -
Differential expression of multidrug resistance-related proteins on monocyte-derived macrophages from rheumatoid arthritis patients
por: Oerlemans, R, et al.
Publicado: (2005) -
Inhibition of tumour necrosis factor alpha production by activated T cells of rheumatoid arthritis patients by novel anti-folate drugs: an ex vivo pilot study
por: van der Heijden, JW, et al.
Publicado: (2005) -
Balancing gastrointestinal benefit–risk in individuals who are prescribed NSAIDs for arthritis
por: Bijlsma, Johannes W. J.
Publicado: (2010)